“Hey! Whatever happened to hemangiopericytoma and fibrosarcoma?” An update on selected conceptual advances in soft tissue pathology which have occurred over the past 50 years
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 95, 113-136
Abstract
No abstract availableKeywords
This publication has 184 references indexed in Scilit:
- Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimicsLaboratory Investigation, 2014
- Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumorGenes, Chromosomes and Cancer, 2013
- High-grade Sarcomatous Overgrowth in Solitary Fibrous TumorsAmerican Journal of Surgical Pathology, 2012
- Low-Grade Fibromyxoid Sarcoma of the Renal Pelvis: First ReportCase Reports in Nephrology and Urology, 2012
- Adult-type Fibrosarcoma: A Reevaluation of 163 Putative Cases Diagnosed at a Single Institution Over a 48-year PeriodAmerican Journal of Surgical Pathology, 2010
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical TrialsJournal of Clinical Oncology, 2010
- The Transcriptional Cofactor Nab2 Is Induced by TGF-β and Suppresses Fibroblast Activation: Physiological Roles and Impaired Expression in SclerodermaPLOS ONE, 2009
- Burn scar sarcomaBurns, 1999
- Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissueJournal of the American Academy of Dermatology, 1993
- Hypertension secondary to a renin-producing juxtaglomerular cell tumorThe Journal of Pediatrics, 1979